Literature DB >> 19052228

The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.

Inna Astapova1, Larissa J Lee, Crystal Morales, Stefanie Tauber, Martin Bilban, Anthony N Hollenberg.   

Abstract

The thyroid hormone receptor (TR) has been proposed to regulate expression of target genes in the absence of triiodothyronine (T(3)) through the recruitment of the corepressors, NCoR and SMRT. Thus, NCoR and SMRT may play an essential role in thyroid hormone action, although this has never been tested in vivo. To accomplish this, we developed mice that express in the liver a mutant NCoR protein (L-NCoRDeltaID) that cannot interact with the TR. L-NCoRDeltaID mice appear grossly normal, however, when made hypothyroid the repression of many positively regulated T(3)-target genes is abrogated, demonstrating that NCoR plays a specific and sufficient role in repression by TR in the absence of T(3). Remarkably, in the euthyroid state, expression of many T(3)-targets is also up-regulated in L-NCoRDeltaID mice, demonstrating that NCoR also determines the magnitude of the response to T(3) in euthyroid animals. Although positive T(3) targets were up-regulated in L-NCoRDeltaID mice in the hypo- and euthyroid state, there was little effect seen on negatively regulated T(3) target genes. Thus, NCoR is a specific regulator of T(3)-action in vivo and mediates repression by the unliganded TR in hypothyroidism. Furthermore, NCoR appears to play a key role in determining the tissue-specific responses to similar levels of circulating T(3). Interestingly, NCoR recruitment to LXR is also impaired in this model, leading to activation of LXR-target genes, further demonstrating that NCoR recruitment regulates multiple nuclear receptor signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052228      PMCID: PMC2614797          DOI: 10.1073/pnas.0804604105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Summaries of Affymetrix GeneChip probe level data.

Authors:  Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Stoichiometric and steric principles governing repression by nuclear hormone receptors.

Authors:  I Zamir; J Zhang; M A Lazar
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

3.  Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis.

Authors:  J H Oppenheimer; H L Schwartz; M I Surks
Journal:  Endocrinology       Date:  1974-09       Impact factor: 4.736

4.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.

Authors:  A J Hörlein; A M Näär; T Heinzel; J Torchia; B Gloss; R Kurokawa; A Ryan; Y Kamei; M Söderström; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

5.  A transcriptional co-repressor that interacts with nuclear hormone receptors.

Authors:  J D Chen; R M Evans
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

6.  The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.

Authors:  Anjali Pawar; Daniela Botolin; David J Mangelsdorf; Donald B Jump
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

7.  Alternative splicing generates multiple SMRT transcripts encoding conserved repressor domains linked to variable transcription factor interaction domains.

Authors:  Marianne Malartre; Stephen Short; Colin Sharpe
Journal:  Nucleic Acids Res       Date:  2004-09-01       Impact factor: 16.971

8.  Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.

Authors:  Brandee L Wagner; Annabel F Valledor; Gang Shao; Chris L Daige; Eric D Bischoff; Mary Petrowski; Kristen Jepsen; Sung Hee Baek; Richard A Heyman; Michael G Rosenfeld; Ira G Schulman; Christopher K Glass
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Dynamic inhibition of nuclear receptor activation by corepressor binding.

Authors:  Young-Chang Sohn; Seung-Whan Kim; Seunghee Lee; Young-Yun Kong; Doe Sun Na; Soo-Kyung Lee; Jae Woon Lee
Journal:  Mol Endocrinol       Date:  2002-12-18

10.  Tissue-specific regulation of lipogenic mRNAs by thyroid hormone.

Authors:  B Blennemann; P Leahy; T S Kim; H C Freake
Journal:  Mol Cell Endocrinol       Date:  1995-04-28       Impact factor: 4.102

View more
  80 in total

1.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

Review 2.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

3.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Another story of mice and men: the types of RTH.

Authors:  Paul Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-03       Impact factor: 11.205

5.  Novel mechanism of positive versus negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver.

Authors:  Preeti Ramadoss; Brian J Abraham; Linus Tsai; Yiming Zhou; Ricardo H Costa-e-Sousa; Felix Ye; Martin Bilban; Keji Zhao; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

6.  Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.

Authors:  Margo P Emont; Stelios Mantis; Jonathan H Kahn; Michael Landeche; Xuan Han; Robert M Sargis; Ronald N Cohen
Journal:  Mol Cell Endocrinol       Date:  2015-03-09       Impact factor: 4.102

7.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

Review 8.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

9.  Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.

Authors:  Balachandar Nedumaran; Gwang Sik Kim; Sungpyo Hong; Young-Sil Yoon; Yong-Hoon Kim; Chul-Ho Lee; Young Chul Lee; Seung-Hoi Koo; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

10.  Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.

Authors:  Laura Fozzatti; Dong Wook Kim; Jeong Won Park; Mark C Willingham; Anthony N Hollenberg; Sheue-Yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.